Use of antipsychotics and risk of myocardial infarction: a systematic review and meta‐analysis
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Aim: There is emerging concern that antipsychotics may be associated with an increased risk of myocardial infarction (MI). A previous review identified five observational studies that did not provide an accurate estimate of the association between antipsychotic drug use and MI risk. More recent studies have produced variable results. Methods: We performed a systematic review and meta‐analysis of observational studies to determine whether antipsychotic use affects the risk for MI. Our analysis included all observational studies that compared MI incidence among patients receiving antipsychotics vs. no treatment. Results: Nine observational studies were included in the analysis. The odds for developing MI were 1.88‐fold higher (odds ratio (OR) 1.88, 95% confidence interval (CI) 1.39, 2.54) in antipsychotic users compared with individuals who had not taken antipsychotics. Subgroup analyses found an OR of 2.48 (95% CI 1.66, 3.69) among patients with schizophrenia and an OR of 2.64 (95% CI 2.48, 2.81) among short term (<30 days) antipsychotic users. Conclusion: The findings of this meta‐analysis support an increased risk of MI in antipsychotic drug users. The present systematic review expands previous knowledge by demonstrating an increased and more pronounced risk in short term users.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pratt, L. A., Ford, D. E., Crum, R. M., Armenian, H. K., Gallo, J. J., & Eaton, W. W. (1996) · Circulation · doi:10.1161/01.cir.94.12.3123 · Cited by 643
Declercq, T., Petrovic, M., Azermai, M., Vander Stichele, R., De Sutter, A. I., van Driel, M. L., & Christiaens, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007726.pub2 · Cited by 206
Management of psychosis and schizophrenia in adults: summary of updated NICE guidance
Kuipers, E., Yesufu-Udechuku, A., Taylor, C., & Kendall, T. (2014) · BMJ · doi:10.1136/bmj.g1173 · Cited by 194
Taylor, D. M., Cornelius, V., Smith, L., & Young, A. H. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12343 · Cited by 122
Correll, C. U., Joffe, B. I., Rosen, L. M., Sullivan, T. B., & Joffe, R. T. (2015) · World Psychiatry · doi:10.1002/wps.20187 · Cited by 102
Ogawa, Y., Tajika, A., Takeshima, N., Hayasaka, Y., & Furukawa, T. A. (2014) · CNS Drugs · doi:10.1007/s40263-014-0197-8 · Cited by 66
Antidepressant use and risk of coronary heart disease: meta‐analysis of observational studies
Oh, S., Kim, J., Myung, S., Hwang, S., & Yoon, D. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12383 · Cited by 40
Cited by
The intriguing relationship between coronary heart disease and mental disorders
De Hert, M., Detraux, J., & Vancampfort, D. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.1/mdehert · Cited by 489
Solmi, M., Murru, A., Pacchiarotti, I., Undurraga, J., Veronese, N., Fornaro, M., Stubbs, B., Monaco, F., Vieta, E., Seeman, M., et al. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s117321 · Cited by 438
Challenges in meta-analyses with observational studies
Metelli, S., & Chaimani, A. (2020) · Evidence Based Mental Health · doi:10.1136/ebmental-2019-300129 · Cited by 290
Zivkovic, S., Koh, C. H., Kaza, N., & Jackson, C. A. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2177-5 · Cited by 65
Zakarias, J. K., Nørgaard, A., Jensen‐Dahm, C., Gasse, C., Laursen, T. M., Palm, H., Nielsen, R. E., & Waldemar, G. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5587 · Cited by 16
Metadata
- Authors
- Yu, Z., Jiang, H., Shao, L., Zhou, Y., Shi, H., & Ruan, B.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2016-05-23
- Volume
- 82
- Issue
- 3
- Pages
- 624-632
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2353617189
- Cited by
- 39
- References
- 7
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.